Krystal Biotech, Inc. KRYS EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s EV / EBITDA?
- Krystal Biotech, Inc. (KRYS) reported EV / EBITDA of 38.3× in Q1 2026.
- How has Krystal Biotech, Inc.'s EV / EBITDA changed year-over-year?
- Krystal Biotech, Inc.'s EV / EBITDA decreased by 10.4% year-over-year, from 42.7× to 38.3×.
- What does EV / EBITDA mean?
- What the whole business (debt included) costs relative to its operating cash earnings.
- How do you interpret EV / EBITDA?
- Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
- How does EV / EBITDA compare across companies?
- Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.